Prevalence and characteristics of hereditary non-polyposis colorectal cancer (HNPCC) syndrome in immigrant Asian colorectal cancer patients

被引:13
作者
Lee, Jasmine [1 ]
Xiao, Yin-Yi [2 ]
Sun, Yan Yu [3 ]
Balderacchi, Jasminka [4 ]
Clark, Bradley [5 ]
Desani, Jatin [6 ]
Kumar, Vivek [7 ]
Saverimuthu, Angela [1 ]
Win, Khin Than [8 ]
Huang, Yiwu [1 ]
Xu, Yiqing [1 ]
机构
[1] Maimonides Hosp, Dept Internal Med, Div Hematol & Oncol, 6300 8th Ave, Brooklyn, NY 11220 USA
[2] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15261 USA
[3] Maimonides Hosp, Dept Pathol, 4802 10th Ave, Brooklyn, NY 11219 USA
[4] CBLPath, 760 Westchester Ave, Rye Brook, NY 10573 USA
[5] Womans Hlth Labs, 3495 Hacks Cross Rd, Memphis, TN 38125 USA
[6] Meridian Med Grp Specialty Care, 1100 Route 72 West,Suite 201, Manahawkin, NJ 08050 USA
[7] Brigham & Womens Hosp, Dept Internal Med, 75 Francis St, Boston, MA 02115 USA
[8] 115 St Nicholas Ave, Brooklyn, NY 11237 USA
关键词
Hnpcc; Asian; Colorectal cancer; Lynch syndrome; Screening; MICROSATELLITE-INSTABILITY; MISMATCH-REPAIR; LYNCH-SYNDROME; FEASIBILITY; CRITERIA; STRATEGY; TUMORS;
D O I
10.1186/s12885-017-3799-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The prevalence of Hereditary Non-Polyposis Colorectal Cancer (HNPCC) is 2 to 5% in the Caucasian population. HNPCC is caused by genomic mutations in DNA mismatch repair genes (MMR), namely MLH1, MSH2, MSH6, PMS2, and EPCAM. A non-hereditary, acquired process of hypermethylation of the MLH1 promoter can also lead to silencing of MLH1 protein expression. Diagnosis of HNPCC in patients with colorectal and other related cancers is important in the clinical treatment and surveillance of related cancers. The prevalence and clinical characteristics of HNPCC in Asian colorectal cancer patients has been reported in small studies and unique features have been suggested. Methods: We retrospectively reviewed the clinical characteristics of Asian patients who were diagnosed of colon cancer between 1/2002 and 6/2015, and performed IHC for four MMR protein expressions on tumor specimens as a screening test for HNPCC, followed by confirmatory tests of genomic sequencing and hypermethylation analysis. Results: One hundred forty-three patients were identified. Thirty-one patients were diagnosed younger than 50 years old, while 112 patients were diagnosed older than 50 years old. Six cases of HNPCC were found with a prevalence of 4. 19%. The prevalence in the group of patients diagnosed younger than 50 years old is 16.1%, and that in patients diagnosed older than 50 years old is 0.89%. All patients with HNPCC had family histories of colon or gastric cancer. Tumor locations in the HNPCC patients were predominantly in the descending or sigmoid colon (67%). Half of the HNPCC patients had MSH6 mutations. Hypermethylation of the MLH1 gene was only present in 2.80% of the patients. Conclusion: The prevalence of HNPCC is high in patients younger than 50 years old and extremely low in those older than 50 years old. These results may be useful in the future development of guidelines for HNPCC laboratory screening among Asian patients. The pathological and clinical features of HNPCC in this group of Asian immigrant patients are more similar to those reported on Asian patients in their home countries than to Caucasian patients in Western countries, and will warrant further large-scale evaluation.
引用
收藏
页数:9
相关论文
共 50 条
[21]   Prostate cancer is part of the hereditary non-polyposis colorectal cancer (HNPCC) tumor spectrum [J].
Soravia, C ;
van der Klift, H ;
Bründler, MA ;
Blouin, JL ;
Wijnen, J ;
Hutter, P ;
Fodde, R ;
Delozier-Blanchet, C .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 121A (02) :159-162
[22]   Tumorigenesis in colorectal tumors from patients with hereditary non-polyposis colorectal cancer [J].
P. Tannergård ;
T. Liu ;
Adolf Weger ;
Magnus Nordenskjöld ;
A. Lindblom .
Human Genetics, 1997, 101 :51-55
[23]   Lynch syndrome (hereditary non-polyposis colorectal cancer): Current concepts and approaches to management [J].
Ricciardiello L. ;
Boland C.R. .
Current Gastroenterology Reports, 2005, 7 (5) :412-420
[24]   Clinical and molecular analysis of hereditary non-polyposis colorectal cancer in Chinese colorectal cancer patients [J].
Wang, Jun ;
Luo, Mao-Hong ;
Zhang, Zuo-Xing ;
Zhang, Pei-Da ;
Jiang, Xi-Li ;
Ma, Dong-Wang ;
Suo, Rong-Zeng ;
Zhao, Li-Zhong ;
Qi, Qing-Hui .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (10) :1612-1617
[25]   Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma [J].
Garg, K. ;
Soslow, R. A. .
JOURNAL OF CLINICAL PATHOLOGY, 2009, 62 (08) :679-684
[26]   Screening for susceptibility genes in hereditary non-polyposis colorectal cancer [J].
Yu, Li ;
Yin, Bo ;
Qu, Kaiying ;
Li, Jingjing ;
Jin, Qiao ;
Liu, Ling ;
Liu, Chunlan ;
Zhu, Yuxing ;
Wang, Qi ;
Peng, Xiaowei ;
Zhou, Jianda ;
Cao, Peiguo ;
Cao, Ke .
ONCOLOGY LETTERS, 2018, 15 (06) :9413-9419
[27]   Pathologic features of hereditary non-polyposis colorectal cancer [J].
Messerini, L ;
Mori, S ;
Zampi, G .
TUMORI, 1996, 82 (02) :114-116
[28]   Genetic diagnosis strategy of hereditary non-polyposis colorectal cancer [J].
Sheng, Jian-Qiu ;
Zhang, Hong ;
Li, Min ;
Fu, Lei ;
Mu, Hong ;
Zhang, Ming-Zhi ;
Huang, Ji-Sheng ;
Han, Min ;
Li, Ai-Qin ;
Wei, Zhi ;
Sun, Zi-Qin ;
Wu, Zi-Tao ;
Xia, Chang-Hong ;
Li, Shi-Rong .
WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (08) :983-989
[29]   Copy Number Variation in Hereditary Non-Polyposis Colorectal Cancer [J].
Masson, Amy L. ;
Talseth-Palmer, Bente A. ;
Evans, Tiffany-Jane ;
Grice, Desma M. ;
Duesing, Konsta ;
Hannan, Garry N. ;
Scott, Rodney J. .
GENES, 2013, 4 (04) :536-555
[30]   Strategies for screening for hereditary non-polyposis colorectal cancer [J].
Loukola, A ;
de la Chapelle, A ;
Aaltonen, LA .
JOURNAL OF MEDICAL GENETICS, 1999, 36 (11) :819-822